Hannah Thomasy, PhD, Drug Discovery News | Jul 14, 2022 | 5 min read
University of Wollongong epidemiologist Gideon Meyerowitz-Katz speaks with The Scientist about his team’s finding that flawed and fraudulent COVID-19 research continues to be cited.
Governments are variable in their reliance on highly cited research, while international intergovernmental organizations such as the World Health Organization reliably link policy and science, according to an analysis of thousands of policy documents from the first half of 2020.
A study makes policy recommendations to optimize citations, but critics say it fails to acknowledge that citations are a biased and narrow measure of scientific success.
Male researchers are more likely to describe their work in publications using positive superlatives than their female colleagues are, a habit tied to more citations.
China shows the biggest increase of any country in the number of scientists listed since last year, while cancer genomics emerges as one of the more dominant fields.
An analysis of contaminated literature finds that tens of thousands of papers used cell lines of questionable origins—and these were in turn cited by hundreds of thousands of other papers.
The Scientist sat down with one of the authors of a recent analysis that quantifies the increasing incursion of open-access content into the world of scholarly publishing.
Consortium pushes for open citation data; Gates Foundation launches open-access publishing platform; Cell Press lifts the veil on papers under consideration; an online widget circumvents some paywalls
Thomson Reuters has transferred the science-citation database, along with the rest of its intellectual property and science division, to private-equity firms.